Disease-modifying Therapy Discontinuation and Outcomes of Older People with Multiple Sclerosis (MS) at a Large Academic MS Center in Toronto, Canada

Rational Design of a Vaccine for Synucleinopathies Using Computationally-Derived Conformational B Cell Epitopes To Selectively Target Pathogenic Alpha-Synuclein Species